These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 18163903)
1. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903 [TBL] [Abstract][Full Text] [Related]
2. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313 [TBL] [Abstract][Full Text] [Related]
3. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077 [TBL] [Abstract][Full Text] [Related]
4. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333 [TBL] [Abstract][Full Text] [Related]
5. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions. Li J; Kleeff J; Esposito I; Kayed H; Felix K; Giese T; Büchler MW; Friess H J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147 [TBL] [Abstract][Full Text] [Related]
7. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814 [TBL] [Abstract][Full Text] [Related]
9. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
10. Loss of ONECUT1 expression in human pancreatic cancer cells. Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
12. [Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions]. Liao Q; Zhao YP; Kleeff J; Xiao Y; Zimmermann A; Buchler MW; Friess H Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):328-31. PubMed ID: 12892583 [TBL] [Abstract][Full Text] [Related]
13. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900 [TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642 [TBL] [Abstract][Full Text] [Related]
16. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307 [TBL] [Abstract][Full Text] [Related]
18. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Zhang ML; Lu S; Zhou L; Zheng SS Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503 [TBL] [Abstract][Full Text] [Related]
19. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Takehara A; Eguchi H; Ohigashi H; Ishikawa O; Kasugai T; Hosokawa M; Katagiri T; Nakamura Y; Nakagawa H Cancer Sci; 2006 Nov; 97(11):1191-7. PubMed ID: 16918991 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]